JPS63149561A - Analysis of prostaglandin - Google Patents

Analysis of prostaglandin

Info

Publication number
JPS63149561A
JPS63149561A JP29485886A JP29485886A JPS63149561A JP S63149561 A JPS63149561 A JP S63149561A JP 29485886 A JP29485886 A JP 29485886A JP 29485886 A JP29485886 A JP 29485886A JP S63149561 A JPS63149561 A JP S63149561A
Authority
JP
Japan
Prior art keywords
liquid
solvent
ethyl acetate
solution
adam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP29485886A
Other languages
Japanese (ja)
Inventor
Hitoshi Iwabuchi
等 岩渕
Yoshimasa Hamano
浜野 吉政
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hitachi Ltd
Original Assignee
Hitachi Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitachi Ltd filed Critical Hitachi Ltd
Priority to JP29485886A priority Critical patent/JPS63149561A/en
Publication of JPS63149561A publication Critical patent/JPS63149561A/en
Pending legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

PURPOSE:To enhance the measuring accuracy of prostaglandin (PG), by analyzing the recovered liquid from a gel permeation column by a liquid chromatograph equipped with a reversed-phase distribution column. CONSTITUTION:9-anthryldiazomethane (ADAM) is reacted with PG to form a PG derivative and ethyl acetate is used as the solvent of an ADAM solution at the time of this reaction to extract PG. Next, the residue after the removal of the solvent is dissolved in methanol and the resulting solution is cooled to precipitate impurities which are, in turn, removed by a centrifugal separation method to remove high-molecular impurities. Subsequently, the solvent is again removed and the liquid of the residue dissolved by ethyl acetate is passed through a gel permeation column and a solution eluted at an early stage is discharged while the residual eluate is recovered. Low-molecular impurities are removed from this recovered liquid. The liquid containing the PG derivative thus obtained is analyzed by a liquid chromatograph equipped with a reversed- phase distribution column. Since ethyl acetate is used as the solvent, the modifi cation of ADAM is reduced and the separation from a water-soluble component becomes good.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、プロスタグランディンの分析方法に係り、特
に液体クロマトグラフを用いた生体試料中のプロスタグ
ランディンの分析方法に関する。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a method for analyzing prostaglandins, and particularly to a method for analyzing prostaglandins in a biological sample using a liquid chromatograph.

〔従来の技術〕[Conventional technology]

プロスタグランディンは、生体機能をコントロールする
重要なホルモン様機能を有する物質であり、これを含有
する生体組織又は生体液を処理して液体クロマトグラフ
で分析することが知られている。
Prostaglandins are substances that have important hormone-like functions that control biological functions, and it is known that biological tissues or fluids containing prostaglandins can be processed and analyzed using liquid chromatography.

特開昭61−202164には、生体試料に、あらかじ
めmmした9−アンスリルジアゾメタンC以下ADAM
と略称する)を作用させてプロスタグランディン(以下
PGと略称する)を誘導体化した後、各種の前処理を施
してから液体クロマトグラフで分析する方法が示されて
いる。
JP-A No. 61-202164 discloses that 9-anthryldiazomethane C or less ADAM, which has been pre-prepared to mm, is added to biological samples.
A method is disclosed in which prostaglandins (hereinafter abbreviated as PG) are derivatized by the action of PG (hereinafter abbreviated as PG), subjected to various pretreatments, and then analyzed with a liquid chromatograph.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

従来は、PGを含む試料と反応させる前にADAMを精
製していた。というのは、市販されているADAMは多
くの共存物質を有しており、そのままでは分析試薬とし
て適用できないからである。一方、ADAM自体は不安
定で変質しやすく、試料中のPGも急速な経時変化を起
こしやすいという問題がある。しかし、PGがADAM
と反応して生じた誘導体は、経時的に安定であり、蛍光
性を有するので、クロマトグラフ分針によって蛍光を検
出して定量することができるので、実用的に利用されて
いる。
Conventionally, ADAM was purified before reacting with a sample containing PG. This is because commercially available ADAM contains many coexisting substances and cannot be used as an analytical reagent as it is. On the other hand, there are problems in that ADAM itself is unstable and easily deteriorates, and PG in the sample also tends to change rapidly over time. However, PG is ADAM
The derivative produced by the reaction with is stable over time and has fluorescence, so the fluorescence can be detected and quantified with a chromatographic minute hand, so it is used practically.

ADAMt−PGとの反応の前に精製すると、精製操作
の間に変質してしまうという問題があった。
When purified before the reaction with ADAMt-PG, there was a problem in that the quality deteriorated during the purification operation.

さらに従来の方法によれば、不純物を十分に除去しきれ
ないという問題があった。
Furthermore, conventional methods have the problem of not being able to sufficiently remove impurities.

本発明の目的は、ADAMの利用効率が高く、PGの変
性も少なくできるPGの分析方法を提供することにある
An object of the present invention is to provide a method for analyzing PG that has high ADAM utilization efficiency and can reduce PG denaturation.

〔問題点を解決するための手段〕[Means for solving problems]

本発明は、プロスタグランディンを含む試料に酢酸エチ
ルを溶媒とした9−アンスリルジアゾメタン溶液を混合
して上記プロスタグランディンを誘導体化し、この液の
溶媒を揮散せしめて除去した後、残留物をメタノール又
はアセトニトリルで溶解し、この溶解液を冷却して不溶
物を析出させ、この析出不溶物を分別除去した液の溶媒
を揮散せしめて除去し、残留物を酢酸エチルで溶解し、
この溶解液をゲルパーミェーションカラムを通して低分
子物質を分離除去し、上記ゲルパーミェーションカラム
からの回収液を逆相分配カラムを備えた液体クロマトグ
ラフで分析することを特徴とする。
The present invention derivatizes the prostaglandin by mixing a sample containing prostaglandin with a solution of 9-anthryldiazomethane using ethyl acetate as a solvent, and removes the solvent by volatilizing the solution, and then removes the residue. Dissolve in methanol or acetonitrile, cool this solution to precipitate insoluble matter, remove the precipitated insoluble matter by evaporating the solvent of the liquid, and dissolve the residue in ethyl acetate,
The method is characterized in that the dissolved solution is passed through a gel permeation column to separate and remove low-molecular substances, and the recovered solution from the gel permeation column is analyzed using a liquid chromatograph equipped with a reverse phase distribution column.

〔作用〕[Effect]

本発明では、冷却保存してあったADAMを最初に精製
するのではなく、精製前にまずPGと反応させPGの誘
導体を形成する。この反応時にはADAM溶液の溶媒と
して酢酸エチルを使用し。
In the present invention, instead of first purifying ADAM that has been stored in cold storage, it is first reacted with PG to form a PG derivative before purification. During this reaction, ethyl acetate was used as a solvent for the ADAM solution.

PGを抽出させる。Let PG be extracted.

次に、溶媒除去した残留物をメタノール又はアセトニト
リルで溶解した液を低温(−20’C)に冷却して夾雑
物を析出させ、析出物を遠心分離法又は濾過法によって
除去する。これによって高分子不純物が除去される。
Next, a solution obtained by dissolving the solvent-removed residue in methanol or acetonitrile is cooled to a low temperature (-20'C) to precipitate impurities, and the precipitate is removed by centrifugation or filtration. This removes polymeric impurities.

次いで、再び溶媒除去し、残留物酢酸エチルで溶解した
液をゲルパーミェーションカラム(以下GPCカラムと
称す)に通し、初期に溶出する溶は排出し、残りの溶出
液を回収する。この回収液では低分子不純物が除去され
ている。かくして得たPG誘導体を含む液を逆相分配カ
ラムを備えた液体クロマトグラフで分析する。
Next, the solvent is removed again, and the residue dissolved in ethyl acetate is passed through a gel permeation column (hereinafter referred to as GPC column), the initially eluted solution is discharged, and the remaining eluate is collected. Low molecular impurities have been removed from this recovered liquid. The liquid containing the PG derivative thus obtained is analyzed using a liquid chromatograph equipped with a reverse phase distribution column.

溶媒として酢酸エチルを用いることにより、通常の溶媒
を用いる場合に比べて、ADAMの変性を低減でき、水
溶性成分との分離性も良くなる。
By using ethyl acetate as a solvent, denaturation of ADAM can be reduced and separation from water-soluble components can be improved, compared to the case where a normal solvent is used.

〔実施例〕〔Example〕

本発明の一実施例の分析操作を第1図に示す。 FIG. 1 shows an analytical operation according to an embodiment of the present invention.

生体試料には、蛋白質を除くための前処理を施す。Biological samples are pretreated to remove proteins.

血清試料または生体組織の1m12を限外濾過法にて処
理し、濾液を回収する。この限外濾過器には、アミコン
社製のセントリーフローCF 25を用いた。
1 ml of serum sample or biological tissue is treated by ultrafiltration and the filtrate is collected. As this ultrafilter, Sentry Flow CF 25 manufactured by Amicon was used.

次に、PGを含む濾液1 m Qに、酢酸エチルで溶解
したA D A M試薬液(0,1%)1m+2を加え
て3分間振盪し、次いで遠心分離器に設置して1000
Gの重力にて遠心分離する。ADAMとの反応によって
生成されたPG誘導体は、酢酸エチル液層内に溶解され
ている。この液層を試験管内に取り出し、温浴上で窒素
ガスを通気させながら、溶媒を揮散せしめ除去する。
Next, 1 m + 2 of ADAM reagent solution (0.1%) dissolved in ethyl acetate was added to 1 m Q of the filtrate containing PG, shaken for 3 minutes, and then placed in a centrifuge at 1000
Centrifuge at G gravity. The PG derivative produced by reaction with ADAM is dissolved in the ethyl acetate liquid layer. This liquid layer is taken out into a test tube, and the solvent is volatilized and removed while blowing nitrogen gas over a hot bath.

乾固された残留物を、1mflのメタノール又はアセト
ニトリルに溶解した後、−20℃にて12時間冷却し、
高分子不純物を析出させる。次にこのけん濁液を遠心分
離器にかけて、析出物を分別し、液層を取り出す。この
場合、遠心分離の代りに濾過を行ってもよい。
The dried residue was dissolved in 1 mfl of methanol or acetonitrile, and then cooled at -20°C for 12 hours.
Precipitates polymeric impurities. Next, this suspension is centrifuged to separate the precipitate and the liquid layer is taken out. In this case, filtration may be performed instead of centrifugation.

取り出された液を試験管内に取り出し、再度温浴上で窒
素ガスを通気させながら、溶媒を揮散せしめて除去し乾
固する。この残留物を100μΩの酢酸エチルで溶解し
、この溶液をGPCカラムに導入し、クロロホルムを溶
離液として分離し、GPCカラムからの初期の溶出液を
排出して残りを回収する。GPCカラムとしては1日立
化成社のGELPADK−R420を用いた。これによ
り、低分子不純物を除去する。
The taken out liquid is taken out into a test tube, and the solvent is volatilized and removed while nitrogen gas is passed through the hot bath again, and the test tube is dried. The residue is dissolved in 100 μΩ ethyl acetate, the solution is introduced into a GPC column and separated using chloroform as eluent, the initial eluate from the GPC column is drained and the remainder is collected. As a GPC column, GELPADK-R420 manufactured by Hitachi Chemical Co., Ltd. was used. This removes low molecular weight impurities.

このようにして分取液として得られた液には。The liquid obtained as a preparative liquid in this way.

従来のものより大幅に不純物が減少されている。Impurities are significantly reduced compared to conventional products.

この分取液を逆相分配カラムを備えた液体クロマトグラ
フで分離分析し、誘導体化されたPGのクロマトグラム
を得る。検出器として蛍光光度計を用いる。
This fractionated liquid is separated and analyzed using a liquid chromatograph equipped with a reverse phase distribution column to obtain a chromatogram of derivatized PG. A fluorometer is used as a detector.

第2図には従来法に基づいて得られたクロマトグラムを
示し、第3図には同じ試料について本発明に基づいて得
られたクロマトグラムを示す、ピーク1はトロンボキサ
ンBz(TXBz)であり。
Figure 2 shows a chromatogram obtained based on the conventional method, and Figure 3 shows a chromatogram obtained for the same sample based on the present invention. Peak 1 is thromboxane Bz (TXBz). .

ピーク2はP G E zであり、ピーク3はP G 
F zαであり、ピーク4は6−ケトPGFzαであり
Peak 2 is P G E z and peak 3 is P G
Fzα, and peak 4 is 6-keto PGFzα.

ピーク5はP G E sである。本発明に基づけば、
不純物によるピークが減少されていることが理解される
Peak 5 is P G E s. Based on the present invention,
It is understood that the peaks due to impurities are reduced.

上述した実施例によれば、試料の前処理時のプロスタグ
ランディンの変性を少なくでき、また、ラベル化剤の精
製は1反応後に行なうことができるので、安定した誘導
体化が可能である。特にプロスタグランディンおよびA
DAM共にそれ自体不安定であるが、誘導体化物は安定
であることから水沫は有効である。クロマトグラムもA
 D A M試薬の高分子領域はメタノールで、低分子
領域はGPC法で除去することにより、定量精度が向上
した。
According to the above embodiments, denaturation of prostaglandin during sample pretreatment can be reduced, and the labeling agent can be purified after one reaction, so stable derivatization is possible. Especially prostaglandins and A
Both DAM and DAM are unstable in themselves, but the derivatized products are stable, so water droplets are effective. Chromatogram is also A
The quantitative accuracy was improved by removing the high molecular region of the DAM reagent with methanol and the low molecular region with GPC method.

〔発明の効果〕〔Effect of the invention〕

発明によれば、A D A Mを変質が進む前に反応に
利用でき、PGの測定精度を向上することかできる。
According to the invention, ADAM can be used for reaction before deterioration progresses, and the accuracy of PG measurement can be improved.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は1本発明の一実施例の分析操作を示す図、第2
は従来法によるクロマトグラムを示す図。 第3図は本発明に基づくクロマトグラムを示す図 、−
1、fl である。                    、
−・・1)・−一 ′
Fig. 1 is a diagram showing the analytical operation of one embodiment of the present invention;
is a diagram showing a chromatogram obtained by a conventional method. FIG. 3 is a diagram showing a chromatogram based on the present invention.
1, fl. ,
−・・1)・−1 ′

Claims (1)

【特許請求の範囲】[Claims] 1、生体組織又は生体液中のプロスタグランデインを液
体クロマトグラフで分析する方法において、プロスタグ
ランデインを含む試料に酢酸エチルを溶媒とした9−ア
ンスリルジアゾメタン溶液を混合して上記プロスタグラ
ンデインを誘導体化し、この液の溶媒を揮散せしめて除
去した後、残留物をメタノール又はアセトニトリルで溶
解し、この溶解液を冷却して不溶物を析出させ、この析
出不溶物を分別除去した液の溶媒を揮散せしめて除去し
、残留物を酢酸エチルで溶解し、この溶解液をゲルパー
ミェーションカラムを通して低分子物質を分離除去し、
上記ゲルパーミェーションカラムからの回収液を逆相分
配カラムを備えた液体クロマトグラフで分析することを
特徴とするプロスタグランデインの分析方法。
1. In a method of analyzing prostaglandin in biological tissues or fluids using liquid chromatography, the above-mentioned prostaglandin is extracted by mixing a 9-anthryldiazomethane solution using ethyl acetate as a solvent with a sample containing prostaglandin. After derivatization and removing the solvent of this liquid by volatilization, the residue is dissolved in methanol or acetonitrile, this solution is cooled to precipitate insoluble materials, and the solvent of the liquid from which the precipitated insoluble materials are separated is removed. The residue was dissolved in ethyl acetate, and the solution was passed through a gel permeation column to separate and remove low-molecular substances.
A method for analyzing prostaglandin, comprising analyzing the liquid recovered from the gel permeation column using a liquid chromatograph equipped with a reversed phase distribution column.
JP29485886A 1986-12-12 1986-12-12 Analysis of prostaglandin Pending JPS63149561A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP29485886A JPS63149561A (en) 1986-12-12 1986-12-12 Analysis of prostaglandin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29485886A JPS63149561A (en) 1986-12-12 1986-12-12 Analysis of prostaglandin

Publications (1)

Publication Number Publication Date
JPS63149561A true JPS63149561A (en) 1988-06-22

Family

ID=17813162

Family Applications (1)

Application Number Title Priority Date Filing Date
JP29485886A Pending JPS63149561A (en) 1986-12-12 1986-12-12 Analysis of prostaglandin

Country Status (1)

Country Link
JP (1) JPS63149561A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997040357A1 (en) * 1996-04-19 1997-10-30 Dainippon Seiki Co., Ltd. Automatic extracting equipment and automatic concentration measuring equipment for component substance in liquid sample
JP2007109716A (en) * 2005-10-11 2007-04-26 Nippon Mektron Ltd Process for producing printed board having cable portion

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997040357A1 (en) * 1996-04-19 1997-10-30 Dainippon Seiki Co., Ltd. Automatic extracting equipment and automatic concentration measuring equipment for component substance in liquid sample
JP2007109716A (en) * 2005-10-11 2007-04-26 Nippon Mektron Ltd Process for producing printed board having cable portion

Similar Documents

Publication Publication Date Title
Harfenist et al. Countercurrent distribution studies with insulin
Rembold et al. Convenient method for the determination of picomole amounts of juvenile hormone
US5578204A (en) Apparatus for recovery and buffer exchange and/or concentration of dissolved macromolecules from a mixture of macromolecules
JPS63149561A (en) Analysis of prostaglandin
CN108445116B (en) Pretreatment method for free oxytocin in organism liquid sample
EP1181537A1 (en) Destructible surfactants and uses thereof
Metrione et al. Subunit structure of dipeptidyl transferase
CN107132293B (en) Novel method for rapidly detecting EETs of brain tissues
JP2024513822A (en) Separation and purification method for tetrahydrocannabivarin by high-speed countercurrent chromatography
JP2007240304A (en) Fractionation apparatus
Goto et al. The simultaneous determination of serum cortisol and cortisone by high-performance liquid chromatography with fluorimetric detection
CN112986428A (en) N-glycosylation liquid phase analysis method of pegylated recombinant human erythropoietin
Baliga et al. A simple method for desalting biological fluids for chromatography.
JP2000310626A (en) Method for preparing sample for analyzing amino acid and kit for analyzing sample
JPS62156559A (en) Preparation of reagent for liquid chromatography and liquid chromatography
JP4683172B2 (en) Purification method of water-soluble dioxetane derivatives
Kinberger et al. Determination of ethosuximide, phenobarbital, carbamazepine, carbamazepine epoxide and phenytoin in serum by high performance liquid chromatography using radially compressed columns and an aqueous methanolic mobile phase
JPH07243952A (en) Method for extracting problem component from sample matrix, thin-film extraction method and method for preparing sample
JP2001056326A (en) Method for refining and measuring serotonin and 5- hydroxyindole acetic acid
Tusell et al. A simple extraction procedure for prostaglandins in human seminal plasma with specific detection by selected ion monitoring
Blondin Analysis of the protein subunit structure of the oligomycin sensitive ATPase proteolipid fraction by reverse phase high pressure liquid chromatography
RU2145511C1 (en) Method of separating mixture of fatty acid c2-c7-fraction by liquid chromatography technique
JP3079554B2 (en) Synthetic DNA purification method
SU1068805A1 (en) Polyhydroxicompound determination method
RU2180566C1 (en) Method to release dihydroquercetin